Sponsored Legislation
To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
HR 679 nullifies recent FDA changes to mifepristone's risk evaluation strategy, limiting HHS's authority and potentially impacting access to medical abortion services.
Build the Wall Act of 2025
HR 816 allocates federal funds to build and maintain a wall along the U.S.-Mexico border, aiming to enhance security and address illegal immigration and drug trafficking.
Pandemic Unemployment Fraud Enforcement Act
The Pandemic Unemployment Fraud Enforcement Act extends the statute of limitations for prosecuting unemployment fraud from 5 to 10 years, enhancing law enforcement's ability to combat fraud.
Combating Illicit Xylazine Act
The Combating Illicit Xylazine Act classifies xylazine as a controlled substance, aiming to curb its misuse in drugs and enhance public health and treatment efforts.